BindingDB logo
myBDB logout

11 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27838184 51 First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington's disease: A proposal to chemists!EBI Dr. Harisingh Gour University
26396678 5 Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders.EBI Therachem Research Medilab (India) Pvt. Ltd.
26207924 32 Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.EBI Colorado College
22942319 16 Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048.EBI CHDI Management/CHDI Foundation
25590515 139 Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.EBI Evotec (U.K.) Ltd
22525315 1 Ianthellamide A, a selective kynurenine-3-hydroxylase inhibitor from the Australian marine sponge Ianthella quadrangulata.EBI Griffith University
8126705 8 Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.EBI Universit£ di Perugia
9873646 41 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.EBI Pharmacia& Upjohn
 4 Synthesis and activity of enantiopure (S) (m-nitrobenzoyl) alanine, potent kynurenine-3-hydroxylase inhibitorEBI TBA
10633043 27 Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents.EBI Glaxo Wellcome Research and Development
9435907 23 Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.EBI F. Hoffmann-La Roche Ltd.